Augustine Therapeutics Raises EUR 17 Million in a Series A First Closing to Advance Lead Candidate Into Clinical Development in Neurological Diseases

View Full Size 

Download

• Full Size JPEG, 900x226, 46.2 KB
• Small JPEG, 480x121, 24.7 KB
• Preview JPEG, 144x36, 7.1 KB
• Thumbnail JPEG, 120x30, 6.6 KB